2289 — Charmacy Pharmaceutical Co Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesAdventurousSmall CapNeutral

Annual income statement for Charmacy Pharmaceutical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	CAS	CAS	CAS	CAS	CAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	3,935	3,493	3,992	3,794	4,175
Cost of Revenue
Gross Profit	229	213	230	225	259
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	3,875	3,438	3,940	3,761	4,054
Operating Profit	60.3	54.4	51.8	32.4	122
Other Net Non Operating Costs
Net Income Before Taxes	63.7	55	54.7	33	122
Provision for Income Taxes
Net Income After Taxes	44.8	40.2	40.6	23.2	90.4
Minority Interest
Net Income Before Extraordinary Items
Net Income	45.4	40.2	40.6	23.2	90.4
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	45.4	40.2	40.6	23.2	90.4
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.43	0.372	0.375	0.213	0.385
Dividends per Share

Discover the metrics influencing Charmacy Pharmaceutical Co's share price